期刊文献+

药物洗脱支架应用于ST段抬高型心肌梗死急诊冠状动脉介入治疗临床分析 被引量:3

Clinical analysis of drug-eluting stents in the emergency percutaneous coronary intervention with ST-segment elevation myocardial Infarction
下载PDF
导出
摘要 目的观察药物洗脱支架应用于急诊冠状动脉介入治疗ST段抬高性型心肌梗死的疗效和安全性。方法选择我院急诊住院的22例ST段抬高性急性心肌梗死患者,男18例,女4例,年龄40—79岁,平均年龄为(60.3±11.7)岁。发病至手术时间为1.5~11h,平均(4.4±2.78)h,在发病12h内急诊行经皮冠状动脉介入(percutaneous coronary interverjtion)治疗,将22例患者植入Firebird和ENDEAVOR支架,并对临床资料,住院期间的心脏事件发生率进行分析,同时对比观察分析两组不同的药物洗脱支架的病变特征,术后住院期间和随访期间再梗死,、死亡等心血管不良事件。结果全部患者造影证实PCI即刻恢复TIM13级血流达到95.7%,4.3%恢复TIM12级血流,改善了ST段抬高型心肌梗死患者的房室传导功能,并发症发生率低。其中两组药物洗脱支架患者住院期间心脏不良事件发生率无显著性差异。住院期间无急性或亚急性血栓形成,在长达两年的随访中,22位病人并未出现心源性死亡,无再发新梗死。结论药物洗脱支架(Firebird支架和ENDEAVOR支架)在急诊冠状动脉介入治疗ST段抬高型心肌梗死中是安全有效的。 Aim To observe the security and therapeutic effect of drug-eluting stent in the emergency percutaneous coronary intervention with ST-segment elevation myocardial infarction. Methods Twenty-two patients ( 18 men,4 women, aged from 40 - 79, mean age 60.3 ± 11.7 years) with ST-segment elevation myocardial infarction were treated by emergency PCI with Firebird stents and ENDEAVOR stents within 12hours. Thedoortoballtimewasfroml. 5 hourstol 1 hours, themeantime ( 4.4 ±2.78 ) hours. Weobservedandanalysed the clinic data and cardiac events and compared the clinic feature and cardiac events such as cardiac death and new myocardial infarction between two kinds of drug-eluting stents in duration of hospital stay and follow-up period. Results The result of angiography showed that after PCI the immediate recovery rate of TIMI grate 3 flow reached 95.7% and the immediate recovery rate of TIMI gratde 2 flow reached 4.3%. The emergency PCI improved the function of atrioventricular conduction and the incident rate of complication was low. No significant difference was observed in-hospital cardiac events between two kinds of drug-eluting stent. There was no acute or subaciate thrombsis in duration of hospital stay and in the next two years follow-up period. There was no cardiac death and new myocardial infarction. Conclusion Implantation of drug-eluting stent in the emergency percutaneous coronary intervention with ST-segment elevation myocardial infarction is safe and effective.
作者 周亮 徐岩
出处 《安徽医药》 CAS 2009年第11期1372-1375,共4页 Anhui Medical and Pharmaceutical Journal
关键词 药物洗脱支架 ST段抬高型心肌梗死 经皮冠状动脉介入术 drug-eluting stent ST-segment elevation myocardial infarction percutaneous coronary intervention
  • 相关文献

参考文献17

  • 1Berger PB, Holmes DR Jr, Ohman EM, et al. Restenosis, reocclusion and adverse cardiovascular events after successfulballoon angioplasty of occluded versus nonoccluded corona - ry arteries. Results from the Muhicenter American Research Trial With Cilazapril After Angio- plasty to Prevent Translu - minal Coronary Obstruction and Resteno- sis (MARCATOR) [ J ]. J Am Coil Cardiol, 1996,27 ( 1 ) : 1 - 7.
  • 2Saito S, Hosokawa FG, Kim K, et al. Primary stent implanta - tion without coumadin in acute myocardial infarction[ J]. J Am Coil Cardiol, 1996,28 ( 1 ) :74 - 81.
  • 3郭继鸿,许俊堂.冠心病介入治疗围手术期的抗凝治疗[J].中国实用内科杂志,2005,25(1):5-7. 被引量:21
  • 4Kobayashi Y, De Gregorio J, Kobayashi N, et al. Stented segment length as an independent predictor of restenosis [ J ]. J Am Coil Cardiol, 1999,34 ( 3 ) :651 - 9.
  • 5彭道地,蒲晓群,杨天伦,郑昭芬,李传昶,邓金华,孟霜缓.西罗莫司药物洗脱支架置入术后14个月支架内完全闭塞一例[J].中国介入心脏病学杂志,2006,14(1):57-57. 被引量:4
  • 6Lim SY, Kim KS ,Joo S J, et al. Very late stent thrombosis after drug - eluting stent implantation in a patient without aspirin and clopidogrel resistance [ J ]. J Korean Med Sci,2008,23 ( 3 ) : 556 - 9.
  • 7Bruno Scheller,Benno Hennen,Bemd Hammer,et al. For the SIAM III study group beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction [ J ]. JACC ,2003,42 (4) :634 - 41.
  • 8Valgimigli M, Percoco G, Malagutti P, et al. STRATEGY Investigators. Tirofiban and sirolimus - eluting stent vs abciximab and bare - metal stent for acute myocardial infarction:a randomized trim [ J ]. JAMA ,2005,293 (17) :2109 - 17.
  • 9Stone GW,Ellis SG,Cox DA,et al. A polymer- based,paclitaxeleluting stent in patients with coronary artery disease [ J ]. N Engl J Med,2004,350(3) :221 -31.
  • 10Degertekin M, Serruys PW, Foley DP, et al. Persistent inhi - bition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term ( up to 2 years) clinical, angiographic, and intravascular ultrasound follow - up[ J]. Circulation ,2002,106 ( 13 ) : 1610 - 3.

二级参考文献2

共引文献72

同被引文献32

  • 1张宇晨,贾三庆,王雷,李虹伟.直接经皮冠状动脉介入治疗患者血浆高敏C反应蛋白水平与心肌灌注的相关性研究[J].中华心血管病杂志,2006,34(5):422-424. 被引量:8
  • 2谢东明,廖伟,钟一鸣,谢东阳,危小军,阳贻红,王小萍,廖永玲.经皮冠状动脉介入治疗(PCI)186例临床分析[J].赣南医学院学报,2007,27(3):339-340. 被引量:1
  • 3汪斌,刘志忠,张丰富.冠状动脉介入诊治中高敏C反应蛋白与造影剂肾病的相关性分析[J].中国医药,2007,2(8):457-459. 被引量:35
  • 4Zacek P,Dominik J,Harrer J,et al.Morbidity and mortality in patients 70 years of age and over undergoing isolated coronary artery bypss surgery[J].Acta Medica(Hradec Kralove),2001,44(2):109-14.
  • 5Cohen HA,Williams DO,Holems DR Jr,et al.Impact of age on procedural and 1-year outcome in percutanous transluminal coronary angioplasty:a report from the NHLBI Dynamic Registy[J].Am Heart,2003,146:513-9.
  • 6Dieker HJ,Brouwer MA,Verheugt FW.ESC guidelines for percutaneous coronary interventions[J].Eur Heart J,2005,26(22):2475.
  • 7Stone GW,Ellis,Cox DA,et al.Apolymer-based,paclitaxel-eluting stent in patients with coronary artery disease[J].N Engl J Med,2004,350(3):221-31.
  • 8Degertekin M,Serruys PW,Foley DP,et al.Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation:long-term(up to 2years)clinical,angiographic,and intravascular ultrasound follow-up[J].Circulation,2002,106(13):1610-3.
  • 9Laarman GJ,Suttorp MJ,Dirksen MT,et al.Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention[J].N Engl J Med,2006,335(11):1105-13.
  • 10Spaulding C,Henry P,Teiger E,et al.Sirolimus-eluting versus uncoated stents in acute myocardial infarction[J].N Engl Jmed,2006,335(11):1093-104.

引证文献3

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部